Alliance to Enhance Shonan Beauty Clinic Brand Recognition in China and Support Growth in Inbound Medical Demand to Japan IRVINE, Calif., Feb. 1, 2026 /PRNewswireAlliance to Enhance Shonan Beauty Clinic Brand Recognition in China and Support Growth in Inbound Medical Demand to Japan IRVINE, Calif., Feb. 1, 2026 /PRNewswire

SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics

2026/02/02 10:30
6 min read

Alliance to Enhance Shonan Beauty Clinic Brand Recognition in China and Support Growth in Inbound Medical Demand to Japan

IRVINE, Calif., Feb. 1, 2026 /PRNewswire/ — SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Medical Corporation Nasukai, a Japan-based medical corporation supported by SBC Medical and the operator of Shonan Beauty Clinic, has entered into a strategic business alliance with Daibi Medical Aesthetics, a medical aesthetic clinic based in Shanghai, China. The alliance aims to enhance the quality of services at Daibi Medical Aesthetics by sharing Nasukai’s clinical expertise, operational know-how, and customer-centered practices cultivated by its long-standing experience in aesthetic medicine. The collaboration also seeks to strengthen recognition in China of the Shonan Beauty Clinic brand’s safety standards and advanced medical technologies.

These efforts aim to deepen SBC Medical’s understanding of China’s medical environment and customer needs, while supporting increased inbound customer visits to Shonan Beauty Clinic in Japan and exploring long-term revenue opportunities associated with growing cross-border medical demand.

Established in 2021, Daibi Medical Aesthetics subsequently opened its clinic in 2022 in Shanghai’s North Bund area. The clinic operates approximately 2,200 square meters of floor space and provides community-based medical aesthetic services. Under the alliance, physicians affiliated with Nasukai will work within Daibi Medical Aesthetics’ clinical framework to share knowledge and expertise related to medical safety, clinic operations, and consultation practices. The two parties will also explore opportunities to promote mutual understanding and professional exchange in the field of aesthetic medicine between Japan and China, with specific initiatives being considered in phases.

The alliance comes amid growing global interest in medical tourism, defined as international travel for the purpose of receiving medical services. According to Fortune Business Insights, the global medical tourism market is projected to grow at a compound annual growth rate (CAGR) of 23.0% from 2024 to 2032, reaching approximately USD 62.18 billion by 2032.

As global interest in medical tourism continues to rise, Japanese aesthetic medicine has gained strong recognition, particularly across Asia, for its advanced medical technologies, safety standards, and attentive consultation practices. Reflecting this trend, inbound customer visits to Shonan Beauty Clinic have increased steadily, nearly tripling from approximately 600 customers in early 2024 to around 1,700 customers by the end of 2025.To support this growing demand, Shonan Beauty Clinic has enhanced its inbound medical infrastructure through initiatives such as the development of Chinese-language translation tools and the renewal of its Chinese and English language official websites, providing overseas customers with clear and reliable medical information and a supportive care environment.

Shonan Beauty Clinic (Chinese): https://cn.sbc-beauty.com/
Shonan Beauty Clinic (English): https://en.sbc-beauty.com/

This alliance is expected to further support these efforts by enabling deeper insight into medical practices and customer expectations in China, contributing to a more seamless and consistent customer experience from pre-visit information to post-treatment follow-up, while also supporting improvements in the quality and reliability of aesthetic medical services at the local level.

Through its consulting and management support for medical institutions including Shonan Beauty Clinic, SBC Medical remains committed to building constructive partnerships with local stakeholders, fostering sustainable international medical exchange through medical tourism, and delivering customer-centered medical care that transcends national and regional boundaries.

About Daibi Medical Aesthetics
Location: Room 3301, No. 1158 Dongdaming Road, Hongkou District, Shanghai, China
CEO: Haibo Yu
Business: Provision of medical aesthetic services

About Nasukai
Location: 2F Maruito Ginza Building, 1-3-9 Ginza, Chuo-ku, Tokyo, Japan
Chairman: Keisuke Takeda
Business: Comprehensive medical services spanning specialized medicine, aesthetic medicine, insured medical care, and elective treatments

About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com/
For more insights and updates from SBC Holdings, follow us on LinkedIn

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

Contacts
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of IR Department E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Head of Public Relations: E-mail: pr@sbc.or.jp

ICR LLC (US Time)
Bill Zima / Managing Partner E-mail: bill.zima@icrinc.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sbc-medical-supported-medical-corporation-nasukai-forms-strategic-alliance-with-daibi-medical-aesthetics-302674945.html

SOURCE SBC Medical Group Holdings Incorporated

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

The post CEO Sandeep Nailwal Shared Highlights About RWA on Polygon appeared on BitcoinEthereumNews.com. Polygon CEO Sandeep Nailwal highlighted Polygon’s lead in global bonds, Spiko US T-Bill, and Spiko Euro T-Bill. Polygon published an X post to share that its roadmap to GigaGas was still scaling. Sentiments around POL price were last seen to be bearish. Polygon CEO Sandeep Nailwal shared key pointers from the Dune and RWA.xyz report. These pertain to highlights about RWA on Polygon. Simultaneously, Polygon underlined its roadmap towards GigaGas. Sentiments around POL price were last seen fumbling under bearish emotions. Polygon CEO Sandeep Nailwal on Polygon RWA CEO Sandeep Nailwal highlighted three key points from the Dune and RWA.xyz report. The Chief Executive of Polygon maintained that Polygon PoS was hosting RWA TVL worth $1.13 billion across 269 assets plus 2,900 holders. Nailwal confirmed from the report that RWA was happening on Polygon. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 The X post published by Polygon CEO Sandeep Nailwal underlined that the ecosystem was leading in global bonds by holding a 62% share of tokenized global bonds. He further highlighted that Polygon was leading with Spiko US T-Bill at approximately 29% share of TVL along with Ethereum, adding that the ecosystem had more than 50% share in the number of holders. Finally, Sandeep highlighted from the report that there was a strong adoption for Spiko Euro T-Bill with 38% share of TVL. He added that 68% of returns were on Polygon across all the chains. Polygon Roadmap to GigaGas In a different update from Polygon, the community…
Share
BitcoinEthereumNews2025/09/18 01:10
SHIB Price Analysis for February 8

SHIB Price Analysis for February 8

The post SHIB Price Analysis for February 8 appeared on BitcoinEthereumNews.com. Original U.Today article Can traders expect SHIB to test the $0.0000070 range soon
Share
BitcoinEthereumNews2026/02/09 00:26
UK Looks to US to Adopt More Crypto-Friendly Approach

UK Looks to US to Adopt More Crypto-Friendly Approach

The post UK Looks to US to Adopt More Crypto-Friendly Approach appeared on BitcoinEthereumNews.com. The UK and US are reportedly preparing to deepen cooperation on digital assets, with Britain looking to copy the Trump administration’s crypto-friendly stance in a bid to boost innovation.  UK Chancellor Rachel Reeves and US Treasury Secretary Scott Bessent discussed on Tuesday how the two nations could strengthen their coordination on crypto, the Financial Times reported on Tuesday, citing people familiar with the matter.  The discussions also involved representatives from crypto companies, including Coinbase, Circle Internet Group and Ripple, with executives from the Bank of America, Barclays and Citi also attending, according to the report. The agreement was made “last-minute” after crypto advocacy groups urged the UK government on Thursday to adopt a more open stance toward the industry, claiming its cautious approach to the sector has left the country lagging in innovation and policy.  Source: Rachel Reeves Deal to include stablecoins, look to unlock adoption Any deal between the countries is likely to include stablecoins, the Financial Times reported, an area of crypto that US President Donald Trump made a policy priority and in which his family has significant business interests. The Financial Times reported on Monday that UK crypto advocacy groups also slammed the Bank of England’s proposal to limit individual stablecoin holdings to between 10,000 British pounds ($13,650) and 20,000 pounds ($27,300), claiming it would be difficult and expensive to implement. UK banks appear to have slowed adoption too, with around 40% of 2,000 recently surveyed crypto investors saying that their banks had either blocked or delayed a payment to a crypto provider.  Many of these actions have been linked to concerns over volatility, fraud and scams. The UK has made some progress on crypto regulation recently, proposing a framework in May that would see crypto exchanges, dealers, and agents treated similarly to traditional finance firms, with…
Share
BitcoinEthereumNews2025/09/18 02:21